Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III study of MenACYW conjugate vaccine in participants 12 months and older in Vietnam
2021-001699-41Phase 3
- Sponsor
- Sanofi
- Start
- Aug 2025
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of Meningococcal ACWY conjugate vaccine in meningococcal disease, sponsored by Sanofi.
02
Drugs
Meningococcal ACWY conjugate vaccine
03
Conditions
meningococcal disease
Beyond the preview
Go deeper on 2021-001699-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-001699-41.